| Complement regulators and inhibitory proteins PF Zipfel, C Skerka Nature Reviews Immunology 9 (10), 729-740, 2009 | 1504 | 2009 |
| Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype M Noris, J Caprioli, E Bresin, C Mossali, G Pianetti, S Gamba, E Daina, ... Clinical Journal of the American Society of Nephrology 5 (10), 1844-1859, 2010 | 1250 | 2010 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 667 | 2017 |
| Complement factor H binds malondialdehyde epitopes and protects from oxidative stress D Weismann, K Hartvigsen, N Lauer, KL Bennett, HPN Scholl, PC Issa, ... Nature 478 (7367), 76-81, 2011 | 589 | 2011 |
| Membranoproliferative glomerulonephritis type II (dense deposit disease): an update GB Appel, HT Cook, G Hageman, JC Jennette, M Kashgarian, ... Journal of the American Society of Nephrology 16 (5), 1392-1403, 2005 | 518 | 2005 |
| Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome T Manuelian, J Hellwage, S Meri, J Caprioli, M Noris, S Heinen, M Jozsi, ... The Journal of clinical investigation 111 (8), 1181-1190, 2003 | 407 | 2003 |
| Comparison Between Two Thymol Formulations in the Control of Varroa destructor: Effectiveness, Persistence, and Residues I Floris, A Satta, P Cabras, VL Garau, A Angioni Journal of economic entomology 97 (2), 187-191, 2004 | 399* | 2004 |
| Factor H autoantibodies in atypical hemolytic uremic syndrome correlate with CFHR1/CFHR3 deficiency M Józsi, C Licht, S Strobel, SLH Zipfel, H Richter, S Heinen, PF Zipfel, ... Blood, The Journal of the American Society of Hematology 111 (3), 1512-1514, 2008 | 394 | 2008 |
| Deletion of Complement Factor H–Related Genes CFHR1 and CFHR3 Is Associated with Atypical Hemolytic Uremic Syndrome PF Zipfel, M Edey, S Heinen, M Józsi, H Richter, J Misselwitz, B Hoppe, ... PLoS genetics 3 (3), e41, 2007 | 388 | 2007 |
| Factor H–related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation S Heinen, A Hartmann, N Lauer, U Wiehl, HM Dahse, S Schirmer, ... Blood, The Journal of the American Society of Hematology 114 (12), 2439-2447, 2009 | 346 | 2009 |
| Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL‐1/reconectin and Factor H P Kraiczy, C Skerka, M Kirschfink, V Brade, PF Zipfel European journal of immunology 31 (6), 1674-1684, 2001 | 340 | 2001 |
| Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners R Pıo, A Martı́nez, EJ Unsworth, JA Kowalak, JA Bengoechea, PF Zipfel, ... Journal of Biological Chemistry 276 (15), 12292-12300, 2001 | 339 | 2001 |
| New approaches to the treatment of dense deposit disease RJH Smith, J Alexander, PN Barlow, M Botto, TL Cassavant, HT Cook, ... Journal of the American Society of Nephrology 18 (9), 2447-2456, 2007 | 337 | 2007 |
| Factor H family proteins and human diseases M Józsi, PF Zipfel Trends in immunology 29 (8), 380-387, 2008 | 334 | 2008 |
| The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20 J Caprioli, P Bettinaglio, PF Zipfel, B Amadei, E Daina, S Gamba, ... Journal of the American Society of Nephrology 12 (2), 297-307, 2001 | 331 | 2001 |
| Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H1. S Kühn, C Skerka, PF Zipfel Journal of immunology (Baltimore, Md.: 1950) 155 (12), 5663-5670, 1995 | 323 | 1995 |
| Atypical aHUS: state of the art CM Nester, T Barbour, SR de Cordoba, MA Dragon-Durey, ... Molecular immunology 67 (1), 31-42, 2015 | 317 | 2015 |
| Factor H family proteins: on complement, microbes and human diseases PF Zipfel, C Skerka, J Hellwage, ST Jokiranta, S Meri, V Brade, P Kraiczy, ... Biochemical Society Transactions 30 (6), 971-978, 2002 | 317 | 2002 |
| C3 glomerulopathy—understanding a rare complement-driven renal disease RJH Smith, GB Appel, AM Blom, HT Cook, VD D’Agati, F Fakhouri, ... Nature reviews nephrology 15 (3), 129-143, 2019 | 314 | 2019 |
| Synthesis of the CC-chemokines MIP-1alpha, MIP-1beta, and RANTES is associated with a type 1 immune response. S Schrum, P Probst, B Fleischer, PF Zipfel Journal of immunology (Baltimore, Md.: 1950) 157 (8), 3598-3604, 1996 | 312 | 1996 |
marina norismario negri institute在 marionegri.it 的电子邮件经过验证
